Katherine S Ventre

7PUBLICATIONS
44CO-AUTHORS
Cancer geneticsPredictive and prognostic markersInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 25, 2026
Genotype-driven tumor ecosystems drive immune evasion and immunotherapy resistance in melanoma.

|Sep 24, 2026
Melanoma evolution in the lymph node shapes systemic outcomes.

|May 18, 2026
Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillance.

|Jun 07, 2024
Lymphatic vessel transit seeds cytotoxic resident memory T cells in skin draining lymph nodes.

Taylor A Heim, Austin C Schultz, Ines Delclaux

|Mar 07, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity.

Katherine S Ventre, Kevin Roehle, Elisa Bello

|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Kevin Roehle, Li Qiang, Katherine S Ventre

Pageof 2

Frequent Collaborators

4 joint publications

Amanda W Lund

3 joint publications

Lestat R Ali

3 joint publications

Li Qiang

3 joint publications

Markus Schober